VHL and nonpapillary renal cell carcinoma: von Hippel-Lindau (VHL) gene mutation was the driving force of various forms of ccRCC and MG-132 mediated proteasome inhibition could make VHL wild type cells sensitive to zafirlukast-induced cell death [73].